Amendment of Schedule 1 to the principal Order

2.  In Schedule 1 to the principal Order (which specifies substances which if included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)—

(a)in relation to the substance Aspirin(1), the entries in columns 2, 3 and 5 numbered “(1)” are re-numbered “(2)”, the entry in column 3 numbered “(2)” is re-numbered “(3)”; and, before those entries re-numbered “(2)”, there are inserted the following entries—

(b)in relation to the substance Beclomethasone Dipropionate(2), in the entry in column 5, for “5,600 mcg” there is substituted “20,000 mcg”;

(c)in relation to the substance Hydrocortisone(3), the entry in each of columns 2 and 5 is, and the entries in column 3 are, numbered “(2)”; and, before the entries in columns 2, 3 and 5, there are inserted the following entries—

(d)in relation to the substance Nystatin, there are inserted the following entries—

(e)there is inserted in column 1, at the appropriate place in the alphabetical order of the entries in that column, each of the following substances—

Candesartan Cilexetil

Lornoxicam

Losartan Potassium

Nebivolol Hydrochloride

Nisoldipine

Propiverine Hydrochloride

Quetiapine Fumarate

Tacalcitol Monohydrate.

(1)

The entry was inserted by S.I. 1997/2044 and amended by S.I. 1998/2081.

(2)

The entry was amended by S.I. 1998/2081.

(3)

The entry was amended by S.I. 1998/108.